Accessibility Menu
Arcadia Biosciences Stock Quote

Arcadia Biosciences (NASDAQ: RKDA)

$3.91
(-20.5%)
-1.01
Price as of October 21, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$3.91
Daily Change
(-20.5%) $1.01
Day's Range
$3.91 - $4.78
Previous Close
$3.91
Open
$4.69
Beta
0.95
Volume
4,580
Average Volume
510,322
Market Cap
5.3M
Market Cap / Employee
$3.91M
52wk Range
$2.53 - $10.31
Revenue
-
Gross Margin
0.38%
Dividend Yield
N/A
EPS
-$5.52
CAPs Rating
-
Industry
Food Products

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Arcadia Biosciences Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
RKDA+13.17%-96.96%-50.28%-100%
S&P+15.06%+95.03%+14.29%+217%

Arcadia Biosciences Company Info

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$1.46M11.4%
Gross Profit$0.63M-6.2%
Gross Margin43.37%-8.2%
Market Cap$5.89M203.5%
Market Cap / Employee$0.65M0.0%
Employees9-57.1%
Net Income-$4.46M-341.0%
EBITDA-$5.96M-197.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.38M-75.0%
Accounts Receivable$1.26M-51.4%
Inventory1.552.2%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.00M-100.0%
Short Term Debt$0.01M-98.0%

Ratios

Q2 2025YOY Change
Return On Assets-56.27%-30.6%
Return On Invested Capital-43.12%60.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$2.03M17.3%
Operating Free Cash Flow-$2.03M17.2%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.320.790.650.6663.61%
Price to Sales0.711.520.771.0935.15%
Price to Tangible Book Value0.320.790.660.6663.72%
Enterprise Value to EBITDA1.69-36.98-0.83-0.24-114.49%
Return on Equity-33.9%-60.8%-7.9%-87.2%126.95%
Total Debt$0.35M$0.16M$0.02M$0.01M-98.08%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.